EUVIMEDOpdag EUVIMED
Crossref

Physician Agency and the Zero‐Markup Drug Policy in China: Evidence From a Structural Model

Qifan Huang, Zhentong Lu, Castiel Chen Zhuang iD

Health Economics · 2025

DOI: 10.1002/hec.70073 ↗

At a glance

Journal article in Health Economics, 2025. Written by Qifan Huang and 2 co-authors. Institution: Meta Platforms Inc., Menlo Park, California, USA. Major MEDLINE topics: Health Policy, Practice Patterns, Physicians', Prescription Drugs. 47 references. Funded by: National Natural Science Foundation of China, Peking University School of Economics Research Seed Grant, Fundamental Research Funds for the Central Universities, Peking University.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

This paper quantifies physician agency in China's prescription drug market by exploiting the structural shift created by the Zero‐Markup Drug Policy. We find that physicians' prescribing decisions are about three times more sensitive to the hospital's profit margin than to the retail price faced by patients. The study provides several key findings. First, government policy exerts a strong influence on drug prices. Second, branded drugs are generally preferred over generics and display lower price elasticity. Third, the policy accounts for more than half of the observed decline in average wholesale prices. Finally, while the policy improves patient welfare, it reduces pharmaceutical firms' sales and profits, and a partial restoration of drug markups could increase overall social welfare.

Subjects

MeSH terms (MEDLINE)

Health PolicyPractice Patterns, Physicians'Prescription DrugsChinaHumansDrug IndustryDrug Costs

Author keywords

hyperlipidemiaphysician agencystructural analysis

Substances

Prescription Drugs

Authors and institutions

  • Meta Platforms Inc., Menlo Park, California, USA.
  • Bank of Canada, Ottawa, Ontario, Canada.
  • Peking University School of Economics, Beijing, China.

ORCID profiles: Castiel Chen Zhuang

Funding

  • National Natural Science Foundation of China
  • Peking University School of Economics Research Seed Grant
  • Fundamental Research Funds for the Central Universities, Peking University

Cite

APA

Huang, Q., Lu, Z., & Zhuang, C. C. (2025). Physician Agency and the Zero‐Markup Drug Policy in China: Evidence From a Structural Model. Health Economics. https://doi.org/10.1002/hec.70073

Vancouver

Huang Q, Lu Z, Zhuang CC. Physician Agency and the Zero‐Markup Drug Policy in China: Evidence From a Structural Model. Health Economics. 2025. doi:10.1002/hec.70073

BibTeX
@article{Huang2025,
  author = {Huang, Qifan and Lu, Zhentong and Zhuang, Castiel Chen},
  title = {Physician Agency and the Zero‐Markup Drug Policy in China: Evidence From a Structural Model},
  journal = {Health Economics},
  year = {2025},
  doi = {10.1002/hec.70073}
}
Start for free →